Natriuresis
Showing 1 - 25 of 136
Cirrhosis, Liver Failure Trial (Empagliflozin 10 MG, Matching Placebo)
Not yet recruiting
- Cirrhosis
- Liver Failure
- Empagliflozin 10 MG
- Matching Placebo
- (no location specified)
Feb 2, 2023
Heart Failure Acute Trial in Groningen (Natriuresis)
Recruiting
- Heart Failure Acute
- Natriuresis
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jan 31, 2023
Heart Failure Trial in Torino (Intensive sodiuria-guided diuretic treatment, Standard diuretic treatment)
Not yet recruiting
- Heart Failure
- Intensive sodiuria-guided diuretic treatment
- Standard diuretic treatment
-
Torino, To, ItalyA.O.U. Città della Salute e della Scienza di Torino
May 25, 2021
Clinical Pharmacology Trial in Neuss (Finerenone (BAY 94-8862) PEG solution, Finerenone (BAY 94-8862) immediate release tablet,
Completed
- Clinical Pharmacology
- Finerenone (BAY 94-8862) PEG solution
- +3 more
-
Neuss, Nordrhein-Westfalen, Germany(unnamed)
Jan 27, 2022
Chronic Heart Failure, Diuretics Drug Reactions, CHF Trial in Haifa (IV Furosemide, IV Furosemide and PO Metolazone, IV
Recruiting
- Chronic Heart Failure
- +2 more
- IV Furosemide
- +2 more
-
Haifa, IsraelRambam MC
Jun 10, 2023
Hypertension, Renal Insufficiency Trial (Questionnaire)
Not yet recruiting
- Hypertension
- Renal Insufficiency
- Questionnaire
- (no location specified)
Sep 5, 2022
Nephrotic Syndrome, Edema, Sodium Retention Trial in Tuebingen (Amiloride, Furosemide)
Recruiting
- Nephrotic Syndrome
- +2 more
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hospital Tuebingen
Nov 1, 2022
End Stage Renal Disease on Dialysis Trial (Empagliflozin 25 mg vs Placebo, Empagliflozin 10 MG)
Not yet recruiting
- End Stage Renal Disease on Dialysis
- Empagliflozin 25 mg vs Placebo
- Empagliflozin 10 MG
- (no location specified)
Dec 22, 2022
Nocturia, Hypertension, Sleep Disturbance Trial in Pittsburgh (BBTI, PM antihypertensive dosing or Chronotherapy, AM
Recruiting
- Nocturia
- +2 more
- BBTI
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Jun 14, 2022
Tools for Estimating Salt and Potassium Intake in Nephrology
Not yet recruiting
- Chronic Kidney Diseases
- administration questionary
- (no location specified)
Mar 13, 2023
Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)
Not yet recruiting
- Kidney Transplant Recipients
- Dapagliflozin 10 MG
- Semaglutide, 1.0 mg/mL
-
Toronto, Ontario, CanadaToronto General Hospital
Jul 6, 2023
Psoriasis Vulgaris Trial in Osijek (Low-Salt Diet)
Recruiting
- Psoriasis Vulgaris
- Low-Salt Diet
-
Osijek, CroatiaUniversity Hospital Osijek
Jun 8, 2023
Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)
Recruiting
- Heart Failure
- LCZ 696
- +4 more
-
New Haven, ConnecticutYale New Haven Hospital
Dec 27, 2022
Dilated Cardiomyopathy Trial in Bani Suwayf (Dapagliflozin Farxiga®, Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone
Recruiting
- Dilated Cardiomyopathy
- Dapagliflozin Farxiga®
- Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone Aldactone®
-
Banī Suwayf, EgyptBeni-suef University
May 7, 2023
Prognostic Value of Hyponatremia in Traumatic Brain Injury
Recruiting
- Traumatic Brain Injury
-
Montpellier, Montepllier, FranceUhmontpellier
Mar 28, 2022
Heart Failure Trial in Genk, Leuven (Combination therapy with acetazolamide and low-dose loop diuretics, High-dose loop
Completed
- Heart Failure
- Combination therapy with acetazolamide and low-dose loop diuretics
- +2 more
-
Genk, Limburg, Belgium
- +1 more
May 11, 2019
Heart Failure Trial in Cairo (myocardial function after surgery)
Recruiting
- Heart Failure
- myocardial function after surgery
-
Cairo, Egypt
- +1 more
Oct 13, 2023
Heart Failure Acute, Heart Failure; With Decompensation Trial in Athens (Spironolactone)
Unknown status
- Heart Failure Acute
- Heart Failure; With Decompensation
-
Athens, Attiki, GreeceLaiko General Hospital
Nov 6, 2020
Heart Failure With Reduced Ejection Fraction Trial in Chicago (SGLT2i, No SGLT2i)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- SGLT2i
- No SGLT2i
-
Chicago, IllinoisUniversity of Chicago
Nov 11, 2022
Tricuspid Regurgitation, Heart Failure With Preserved Ejection Fraction Trial (Enavogliflozin, Placebo)
Not yet recruiting
- Tricuspid Regurgitation
- Heart Failure With Preserved Ejection Fraction
- Enavogliflozin
- Placebo
- (no location specified)
Aug 31, 2023
Right Sided Cardiac Failure Trial in Baltimore (Water immersion)
Completed
- Right Sided Cardiac Failure
- Water immersion
-
Baltimore, MarylandUniversity of Maryland
Feb 23, 2022
Cirrhosis, Liver, Liver Fibrosis, Ascites Hepatic Trial in Chandler, Rochester (PHIN-214 Subcutaneous injection)
Recruiting
- Cirrhosis, Liver
- +2 more
- PHIN-214 Subcutaneous injection
-
Chandler, Arizona
- +1 more
Aug 4, 2022
Hypertension, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (Heating pad, Sham control)
Recruiting
- Hypertension
- +3 more
- Heating pad
- Sham control
-
Nashville, TennesseeAutonomic Dysfunction Center/ Vanderbilt University Medical Cent
Jan 6, 2022
Acute Decompensated Heart Failure Trial in Chicago (SGLT2i, No SGLT2i)
Not yet recruiting
- Acute Decompensated Heart Failure
- SGLT2i
- No SGLT2i
-
Chicago, IllinoisUniversity of Chicago
Jun 10, 2022